Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

Core Points - Teva Pharmaceutical Industries Ltd. will release its fourth quarter 2025 financial results on January 28, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET [1] - A live webcast of the conference call will be available on Teva's website, with a replay accessible within 24 hours after the call [2] - Teva is transforming into a leading innovative biopharmaceutical company, supported by a strong generics business, focusing on neuroscience, immunology, complex generics, biosimilars, and pharmacy brands [3]